Human carboxylesterases: An update on CES1, CES2 and CES3

Protein and Peptide Letters

Volumn 16, Issue 10, 2009, Pages 1207-1214

  Sanghani, Sonal P ^a,b   Sanghani, Paresh C ^a   Schiel, Marissa A ^a   Bosron, William F ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Alignment; Alternative splicing; Carboxylesterase; Drug metabolism; Enzyme kinetics; Homology modeling; Hydrolase; Review; Single nucleotide polymorphisms; Splice variants; Substrate specificity

Indexed keywords

CARBOXYLESTERASE; CARBOXYLESTERASE 2, HUMAN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; CHROMOSOME 16; ENZYME SPECIFICITY; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CARBOXYLESTERASE; CHROMOSOMES, HUMAN, PAIR 16; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY;

EID: 69549137840     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609789071324     Document Type: Article

References (48)

1. Hosokawa, M. Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. Molecules, 2008, 13(2), 412-431.
2. Hosokawa, M.; Furihata, T.; Yaginuma, Y.; Yamamoto, N.; Koyano, N.; Fujii, A.; Nagahara, Y.; Satoh, T.; Chiba, K. Genomic structure and transcriptional regulation of the rat, mouse, and human carboxylesterase genes. Drug Metab. Rev., 2007, 39(1), 1-15.
3. Satoh, T.; Hosokawa, M. Structure, function and regulation of carboxylesterases. Chem. Biol. Interact., 2006, 162(3), 195-211.
4. Imai, T. Human carboxylesterase isozymes: catalytic properties and rational drug design. Drug. Metab. Pharmacokinet., 2006, 21(3), 173-185.
5. Redinbo, M.R.; Potter, P.M. Keynote review: Mammalian carboxylesterases: From drug targets to protein therapeutics. Drug Discov. Today, 2005, 10(5), 313-325.
6. Riddles, P.W.; Richards, L.J.; Bowles, M.R.; Pond, S.M. Cloning and analysis of a cDNA encoding a human liver carboxylesterase. Gene, 1991, 108(2), 289-292.
7. Munger, J.S.; Shi, G.P.; Mark, E.A.; Chin, D.T.; Gerard, C.; Chapman, H.A. A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J. Biol. Chem., 1991, 266(28), 18832-18838.
8. Takai, S.; Matsuda, A.; Usami, Y.; Adachi, T.; Sugiyama, T.; Katagiri, Y.; Tatematsu, M.; Hirano, K. Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. Biol. Pharm. Bull., 1997, 20(8), 869-873.
9. Brzezinski, M.R.; Spink, B.J.; Dean, R.A.; Berkman, C.E.; Cashman, J.R.; Bosron, W.F. Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. Drug Metab. Dispos., 1997, 25(9), 1089-1096.
10. Hosokawa, M.; Furihata, T.; Yaginuma, Y.; Yamamoto, N.; Watanabe, N.; Tsukada, E.; Ohhata, Y.; Kobayashi, K.; Satoh, T.; Chiba, K. Structural organization and characterization of the regulatory element of the human carboxylesterase (CES1A1 and CES1A2) genes. Drug Metab. Pharmacokinet., 2008, 23(1), 73-84.
11. Bencharit, S.; Morton, C.L.; Xue, Y.; Potter, P.M.; Redinbo, M.R. Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. Nat. Struct. Biol., 2003, 10(5), 349-356.
12. Pindel, E.V.; Kedishvili, N.Y.; Abraham, T.L.; Brzezinski, M.R.; Zhang, J.; Dean, R.A.; Bosron, W.F. Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J. Biol. Chem., 1997, 272(23), 14769-14775. (Pubitemid 27251744)
13. Schwer, H.; Langmann, T.; Daig, R.; Becker, A.; Aslanidis, C.; Schmitz, G. Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem. Biophys. Res. Commun., 1997, 233(1), 117-120.
14. Sanghani, S.P.; Quinney, S.K.; Fredenburg, T.B.; Sun, Z.; Davis, W.I.; Murry, D.J.; Cummings, O.W.; Seitz, D.E.; Bosron, W.F. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. Clin. Cancer Res., 2003, 9(13), 4983-4991.
15. Satoh, T.; Taylor, P.; Bosron, W.F.; Sanghani, S.P.; Hosokawa, M.; La Du, B.N. Current progress on esterases: from molecular structure to function. Drug Metab Dispos., 2002, 30(5), 488-493.
16. Bencharit, S.; Edwards, C.C.; Morton, C.L.; Howard-Williams, E.L.; Kuhn, P.; Potter, P.M.; Redinbo, M.R. Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1. J. Mol. Biol., 2006, 363(1), 201-214.
17. Eyre, T.A.; Ducluzeau, F.; Sneddon, T.P.; Povey, S.; Bruford, E.A.; Lush, M.J. The HUGO Gene Nomenclature Database, 2006 updates. Nucleic Acids Res., 2006, 34 (Database issue), D319-D321.
18. Yan, B.; Matoney, L.; Yang, D. Human carboxylesterases in term placentae: enzymatic characterization, molecular cloning and evidence for the existence of multiple forms. Placenta, 1999, 20(7), 599-607.
19. Maglott, D.; Ostell, J.; Pruitt, K.D.; Tatusova, T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res., 2007, 35 (Database issue), D26-D31.
20. Zhang, J.; Feuk, L.; Duggan, G.E.; Khaja, R.; Scherer, S.W. Development of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome. Cytogenet. Genome Res., 2006, 115(3-4), 205-214.
21. Stamm, S.; Ben-Ari, S.; Rafalska, I.; Tang, Y.; Zhang, Z.; Toiber, D.; Thanaraj, T.A.; Soreq, H. Function of alternative splicing. Gene, 2005, 344, 1-20.
22. Garcia-Blanco, M.A.; Baraniak, A.P.; Lasda, E.L. Alternative splicing in disease and therapy. Nat. Biotechnol., 2004, 22(5), 535-546.
23. Venables, J.P. Aberrant and alternative splicing in cancer. Cancer Res., 2004, 64(21), 7647-7654.
24. Thierry-Mieg, D.; Thierry-Mieg, J. AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol., 2006, 7(Suppl 1), S12.
25. Kroetz, D.L.; McBride, O.W.; Gonzalez, F.J. Glycosylationdependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. Biochemistry, 1993, 32(43), 11606-11617.
26. Schiel, M.A.; Green, S.L.; Davis, W.I.; Sanghani, P.C.; Bosron, W.F.; Sanghani, S.P. Expression and characterization of a human carboxylesterase 2 splice variant. J. Pharmacol. Exp. Ther., 2007, 323(1), 94-101.
27. Wu, M.H.; Chen, P.; Remo, B.F.; Cook, E.H.; Jr.; Das, S.; Dolan, M.E. Characterization of multiple promoters in the human carboxylesterase 2 gene. Pharmacogenetics., 2003, 13(7), 425-435.
28. Sanghani, S.P.; Quinney, S.K.; Fredenburg, T.B.; Davis, W.I.; Murry, D.J.; Bosron, W.F. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1- piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1- piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3. Drug Metab. Dispos., 2004, 32(5), 505-511.
29. Saito, S.; Iida, A.; Sekine, A.; Kawauchi, S.; Higuchi, S.; Ogawa, C.; Nakamura, Y. Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population. J. Hum. Genet., 2003, 48(5), 249-270.
30. Marsh, S.; Xiao, M.; Yu, J.; Ahluwalia, R.; Minton, M.; Freimuth, R.R.; Kwok, P.Y.; McLeod, H.L. Pharmacogenomic assessment of carboxylesterases 1 and 2. Genomics, 2004, 84(4), 661-668.
31. Charasson, V.; Bellott, R.; Meynard, D.; Longy, M.; Gorry, P.; Robert, J. Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38. Clin. Pharmacol. Ther., 2004, 76(6), 528-535.
32. Kim, S.R.; Nakamura, T.; Saito, Y.; Sai, K.; Nakajima, T.; Saito, H.; Shirao, K.; Minami, H.; Ohtsu, A.; Yoshida, T.; Saijo, N.; Ozawa, S.; Sawada, J. Twelve novel single nucleotide polymorphisms in the CES2 gene encoding human carboxylesterase 2 (hCE-2). Drug Metab. Pharmacokinet., 2003, 18(5), 327-332.
33. Wu, M.H.; Chen, P.; Wu, X.; Liu, W.; Strom, S.; Das, S.; Cook, E.H.; Jr.; Rosner, G.L.; Dolan, M.E. Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene. Pharmacogenetics, 2004, 14(9), 595-605.
34. Bencharit, S.; Morton, C.L.; Hyatt, J.L.; Kuhn, P.; Danks, M.K.; Potter, P.M.; Redinbo, M.R. Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition. Chem. Biol., 2003, 10(4), 341-349.
35. Zhu, H.J.; Patrick, K.S.; Yuan, H.J.; Wang, J.S.; Donovan, J.L.; DeVane, C.L.; Malcolm, R.; Johnson, J.A.; Youngblood, G.L.; Sweet, D.H.; Langaee, T.Y.; Markowitz, J.S. Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am. J. Hum. Genet., 2008, 82(6), 1241-1248.
36. Sun, Z.; Murry, D.J.; Sanghani, S.P.; Davis, W.I.; Kedishvili, N.Y.; Zou, Q.; Hurley, T.D.; Bosron, W.F. Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1. J. Pharmacol. Exp. Ther., 2004, 310(2), 469-476.
37. Kubo, T.; Kim, S.R.; Sai, K.; Saito, Y.; Nakajima, T.; Matsumoto, K.; Saito, H.; Shirao, K.; Yamamoto, N.; Minami, H.; Ohtsu, A.; Yoshida, T.; Saijo, N.; Ohno, Y.; Ozawa, S.; Sawada, J. Functional characterization of three naturally occurring single nucleotide polymorphisms in the CES2 gene encoding carboxylesterase 2 (HCE- 2). Drug Metab Dispos., 2005, 33(10), 1482-1487.
38. Quinney, S.K.; Sanghani, S.P.; Davis, W.I.; Hurley, T.D.; Sun, Z.; Murry, D.J.; Bosron, W.F. Hydrolysis of capecitabine to 5'-deoxy- 5-fluorocytidine by human carboxylesterases and inhibition by loperamide. J. Pharmacol. Exp. Ther., 2005, 313(3), 1011-1016.
39. Hotelier, T.; Renault, L.; Cousin, X.; Negre, V.; Marchot, P.; Chatonnet, A. ESTHER, the database of the alpha/beta-hydrolase fold superfamily of proteins. Nucleic Acids Res., 2004, 32 (Database issue), D145-D147.
40. Brzezinski, M.R.; Abraham, T.L.; Stone, C.L.; Dean, R.A.; Bosron, W.F. Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochem. Pharmacol., 1994, 48(9), 1747-1755.
41. Testa, B.; Mayer J. In Hydrolysis in drug and prodrug metabolism : chemistry, biochemistry, and enzymology; Wiley-VCH: Zürich: VHCA ; Weinheim, 2003; pp. 47-79.
42. Satoh, T.; Hosokawa, M. The mammalian carboxylesterases: from molecules to functions. Annu. Rev. Pharmacol. Toxicol., 1998, 38, 257-288.
43. Dean, R.A.; Christian, C.D.; Sample, R.H.; Bosron, W.F. Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine. FASEB J., 1991, 5(12), 2735-2739.
44. Bosron, W.F.; Hurley, T.D. Lessons from a bacterial cocaine esterase. Nat. Struct. Biol., 2002, 9(1), 4-5.
45. Imai, T.; Taketani, M.; Shii, M.; Hosokawa, M.; Chiba, K. Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine. Drug Metab. Dispos., 2006, 34(10), 1734-1741.
46. Hearn, W.L.; Flynn, D.D.; Hime, G.W.; Rose, S.;Cofino, J.C.; Mantero-Atienza, E.; Wetli, C.V.; Mash, D.C. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J. Neurochem., 1991, 56(2), 698-701.
47. Bourland, J.A.; Martin, D.K.; Mayersohn, M. Carboxylesterasemediated transesterification of meperidine (Demerol) and methylphenidate (Ritalin) in the presence of [2H6]ethanol: preliminary in vitro findings using a rat liver preparation. J. Pharm. Sci., 1997, 86(12), 1494-1496.
48. Ingelman-Sundberg, M.; Sim, S.C.; Gomez, A.; Rodriguez-Antona, C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther., 2007, 116(3), 496-526.